InvestorsHub Logo
Post# of 253651
Next 10
Followers 839
Posts 120736
Boards Moderated 13
Alias Born 09/05/2002

Re: oldberkeley post# 192091

Saturday, 06/06/2015 1:54:17 PM

Saturday, June 06, 2015 1:54:17 PM

Post# of 253651
If FDA ends up approving Addyi (flibanserin), it will be a sort of “make-up call,” IMO. I.e. the FDA probably should have approved PG’s Intrinsa ten years ago, but there was a lot of overblown discussion of the safety risks and PG eventually dropped the program. If there were (hypothetically) a head-to-head study of Intrinsa vs Addyi, I would be willing to bet that Intrinsa would prove to be more efficacious and probably safer too.

I think FSDD deserves to be treated as a real disorder, but Addyi is the wrong drug for the task.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.